24 April 2020 - Deborah Wilkes
Archived
Danish pharmaceutical company Orifarm is acquiring a portfolio of OTC and prescription pharmaceuticals sold in Europe from Japan’s Takeda in a deal worth up to approximately USD670 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.